Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions

Patricia A. Taylor(National Jewish Health), Bruce R. Blazar(University of Minnesota Medical Center)
Blood
October 16, 2002
Cited by 95


Related Papers